GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the BTB domain of human KCTD17

Analyse Crystal structure of the BTB domain of human KCTD17 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5A6R
Type
protein
Length
507 residues
Chains
5
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.85
Source
HOMO SAPIENS
Molecule
BTB/POZ domain-containing protein KCTD17
UniProt
Q8N5Z5
Pockets
6 · best druggability 0.71

Structure

x-ray diffraction · resolution 2.85 · 2 distinct chains · 42% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CBTB/POZ domain-containing protein KCTD17protein10242% helix, 16% strandQ8N5Z5
B, D, EBTB/POZ domain-containing protein KCTD17protein10142% helix, 16% strandQ8N5Z5

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111100.710.75103empty
21220.430.7618empty
31160.420.7619empty
41130.410.7620empty
51010.410.7719empty

Interfaces

8 interfaces between chains.

  • D–E · 808 Ų buried · 16 hydrogen bonds · protein-protein
  • C–E · 791 Ų buried · 16 hydrogen bonds · protein-protein
  • B–C · 790 Ų buried · 18 hydrogen bonds · protein-protein
  • A–B · 787 Ų buried · 16 hydrogen bonds · protein-protein
  • A–D · 756 Ų buried · 15 hydrogen bonds · protein-protein

Compared structures

  • 5A6R · Crystal structure of the btb domain of human KCTD17 · the same entry in another collection · chain B against B, TM-score 1.00
  • Q8N5Z5 · AlphaFold monomer V2.0 prediction for BTB/POZ domain-containing protein KCTD17 (Q8N5Z5) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.